Deoxyrhapontin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Desoxyrhaponticin和rhaponticin被认为是有前途的脂肪酸合酶（FAS）抑制剂，它们可以抑制细胞内FAS活性并下调人乳腺癌MCF-7细胞中FAS的表达。

Desoxyrhaponticin is an agent that is potentially effective in controlling postprandial hyperglycemia in diabetes, the in vivo antidiabetic action of this compound can be explained, in part at least, by inhibition of glucose transport in the small intestine and inhibition of glucose reabsorption in the kidney. Desoxyrhaponticin and rhaponticin could be considered as promising fatty acid synthase(FAS) inhibitors, they could inhibit intracellular FAS activity and downregulate FAS expression in human breast cancer MCF-7 cells.

——

——

——

Microbiology/Virology

HIV

FAS

Others-Field

——

30197-14-9

404.41

C21H24O8

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (247.27 mM)

COC1=CC=C(C=C1)C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O

——

(-20℃)

With Ice Pack

≥ 2 years